Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Veeva Systems Inc.NYSE: VEEV

Gross Profit · Q2 FY2027 · quarter ended Jul 2026

Gross profit grows in line with its trailing trend

Q2 FY2027 gross profit of $695.95M rose 17.2% year over year, ahead of the +15.4% change in trailing-twelve-month gross profit. Sequentially, it rose 5.5% from the prior quarter. Over 3 fiscal years it compounded at +16.0% a year.

Context

  • Gross profit amounted to 75.5% of revenue in FY2026, up 1.0 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +17.2% holds above the trailing-twelve-month pace of +15.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
$695.95M+5.5% QoQ
Last fiscal yearJan 2026
$2.41B+17.9% YoY
LTMJul 2026
$2.59B+15.4% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+17.2%——
1 year+17.9%——
3-year CAGR+16.0%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2026
2.41B USD
Year-over-year change
+17.9%
4-year CAGR
+15.7%

Gross Profit vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 gross profit of $2.59B is the 2nd highest of the 5 companies compared; the peer median is $388.37M.
  • Its year-over-year change of +15.4% is the highest of 5, against a peer median of +3.5%.
  • Gross profit amounts to 74.9% of revenue for VEEV, versus a peer median of 61.7%.
VEEV Competitors Peer median
Gross Profit for VEEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$4.46B -17.1%+2.6%26.2%
VEEVVeeva Systems Inc.LTM Jul 2026$2.59B +15.4%+16.0%74.9%
DOCSDoximity, Inc.LTM Sep 2026$574.43M +2.5%+16.3%86.8%
HSTMHealthStream, Inc.LTM Mar 2026$202.3M +4.5%+3.9%64.9%
SDGRSchrödinger, Inc.LTM Sep 2026$157.53M +5.4%+12.2%58.5%
Peer median (excluding VEEV) $388.37M+3.5%+8.0%61.7%

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Revenue1.85B2.16B2.36B2.75B3.2B
Cost of Revenue503.68M609.41M677.29M699.64M782.02M
Gross Profit1.35B1.55B1.69B2.05B2.41B
Gross Margin72.8%71.7%71.3%74.5%75.5%
Research & Development382.04M520.28M629.03M693.08M767.39M
Selling, General & Admin459.57M566.29M628.02M662.47M729.54M
Operating Expenses841.6M1.09B1.26B1.36B1.5B
Depreciation & Amortization27.45M29.12M32.63M39.38M50.47M
EBITDA539.76M538.22M620.65M958.76M1.24B
EBITDA Margin29.2%25.0%26.3%34.9%39.0%
Operating Income505.5M459.09M429.33M691.44M916.37M
Operating Margin27.3%21.3%18.2%25.2%28.7%
Interest Income14.73M45.86M133.75M207.99M0
Interest Expense00000
Other Income / Expenses6.82M50.01M158.69M227.95M278.14M
Income Before Tax512.31M509.1M588.02M919.38M1.19B
Pre-Tax Margin27.7%23.6%24.9%33.5%37.4%
Income Tax Expense84.92M21.39M62.32M205.24M285.6M
Net Income427.39M487.71M525.71M714.14M908.91M
Net Margin23.1%22.6%22.2%26.0%28.4%
EPS (Basic)2.793.143.274.415.55
EPS (Diluted)2.633.003.224.325.44
Weighted Avg Shares153.25M155.39M160.53M161.88M163.67M
Weighted Avg Shares (Diluted)162.28M162.44M163.49M165.23M167M

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.